Jonathan Rothberg

Jonathan Rothberg is an Adjunct Professor of Research in Genetics at Yale School of Medicine. He is renowned for inventing next-generation DNA sequencing technologies, founding companies like 454 Life Sciences and Ion Torrent, and pioneering projects such as the first human genome sequencing (James Watson) and the Neanderthal Genome Project. Educated at Carnegie Mellon University (B.S. Chemical Engineering) and Yale University (Ph.D. Biology), Rothberg's work has revolutionized molecular diagnostics and healthcare technology. His innovations, including semiconductor chip-based sequencing, earned recognition from Science and Nature. He leads ventures in genomics, medical imaging (e.g., Butterfly Network), and health equity research.

Education:

• B.S., Chemical Engineering, Carnegie Mellon University
• M.S., M.Phil., Ph.D., Biology, Yale University

Research Interests: Focuses on genomic technologies, biotech entrepreneurship, and translational medicine. Key areas include cancer genomics, ancient DNA analysis, and semiconductor-based diagnostics. His work bridges engineering, AI, and biology to address global health challenges.

Awards:

• World Economic Forum Technology Pioneer (4x)
• Nature Methods Innovation Award
• Connecticut Medal of Technology
• Member, National Academy of Engineering

Labs & Ventures: Leads Butterfly Network (ultrasound-on-a-chip), Hyperfine Research, and Quantum-Si, collaborating with MIT and IBM on AI-driven healthcare solutions. Active in non-profits targeting childhood diseases and cancer genomics.